Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
about
The Incremental Induction of Neuroprotective Properties by Multiple Therapeutic Strategies for Primary and Secondary Neural InjuryPromoting remyelination in multiple sclerosis-recent advancesFeasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosisCirculating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisRelationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritisComplement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament LightQuantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelinationA changing treatment landscape for multiple sclerosis: challenges and opportunities.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Late onset multiple sclerosis: concerns in aging patients.Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide.The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.Defining active progressive multiple sclerosis.Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.The relationship of age with the clinical phenotype in multiple sclerosis.Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - YES.Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
P2860
Q26795755-DF6E904E-68C6-4965-B616-1FB0DC88F34BQ27010398-4568076E-C625-46DF-B829-153D19561DA6Q28535303-1D898F8E-3A25-422C-8A66-70994E5A7E7AQ34524908-6EAB48BC-EBE2-41E2-A94A-056C45DFF975Q35015106-4829E417-020D-47E6-9A5A-D1127F6A1DC4Q35250966-E3716060-5942-4518-8545-9AB363167890Q35681358-800A9E8B-7459-4C2D-83F0-03C732DCF6F3Q36394016-CB650378-A102-4D30-8C3F-721372A3F85BQ36451661-C8841B82-3FF7-42EE-8FE8-451F78CBE2C8Q38180166-E0C29EB1-4B96-4318-BDDA-CE77A38FD48BQ38590773-632AEE58-765F-4ED9-9941-63E2BC41A9C2Q38660110-1F199C7A-8333-495B-BF9C-D9C16CEC3657Q39025444-0C72D574-3937-48B6-BB49-A444FE704F40Q39272304-2729099F-A4E7-4A56-A17A-896663A7C5DDQ40468324-9C35F415-6DC0-4651-83D4-68B47D4A24CBQ43426688-E37D0737-D63D-4D14-9E2E-E66DD63AC755Q43532290-31070869-BE63-4BBD-9555-A833EA5C87FAQ47918387-968AA2A2-C912-43D5-B41B-926D65F659CFQ48217814-9EC3E7DB-AA64-430A-90D6-E0B9D99F99E9Q48910491-40039792-3D8F-435C-9C6A-E02C5614999FQ48912523-41FDE3F0-D315-4201-945A-C7054D2540A1Q50777713-666DAEB4-123D-4841-A685-1D2A6504AD57Q53181985-F7F38CD0-5F07-4704-AAE7-71F030A1713DQ53212006-41AB4C73-F5B9-40E9-B70B-A8548680AA43
P2860
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@ast
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@en
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@nl
type
label
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@ast
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@en
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@nl
prefLabel
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@ast
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@en
Intense inflammation and nerve ...... erebrospinal fluid biomarkers.
@nl
P2093
P2860
P50
P921
P1433
P1476
Intense inflammation and nerve ...... cerebrospinal fluid biomarkers
@en
P2093
Ann M Dring
Fredrik Piehl
Magnus Andersson
Robert A Harris
Tomas Olsson
P2860
P304
P356
10.1371/JOURNAL.PONE.0063172
P407
P50
P577
2013-05-07T00:00:00Z